Blutungsneigung
-
Long-term secondary prophylaxis in children, adolescents and young adults with von Willebrand disease
2011 February 8 - Thrombosis and Haemostasis 105.4 -
Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma-derived or recombinant factor VIII concentrates: a systematic review
2010 - Journal of Thrombosis and Haemostasis, 8: 1256–1265 -
Multiplate® Whole Blood Impedance Point of Care Aggregometry: Preliminary Reference Values in Healthy Infants, Children and Adolescents
2010 - Klin Padiatr; 222: 158 – 163 Association of the protein Z ATG haplotype with symptomatic nonvascular stroke or thromboembolism in white children: a family-based cohort study
2009 March 05 - Blood, vol 113, No 10; 2336-2341Effects of primary and secondary prophylaxis on the clinical expression of joint damage in children with severe haemophilia A
Results of a multicenter non-concurrent cohort study
2008 - Thromb Haemost; 99: 71-76Request for further standardization issues for future studies in paediatric haemophilia - Rebuttal to "Including the life-time cumulative number of joint bleeds in the definition of primary prophylaxis"
2008 - Thromb Haemost; 99: 966-968Interferences in coagulation tests - evaluation of the 570-nm method on the Dade Behring BCS analyser
2005 - Clin Chem Lab Med 2005;43(2):244-252Spectrum of Molecular Defects and Mutation Detection Rate in Patients With Severe Hemophilia A
2005 - Human Mutation 26(3),249-254Catheter-related thrombosis in children with hemophilia A: evidence of a multifactorial disease
2002 February - Blood;99,4:1499-1500Prevalence of Small Rearrangements in the Factor VIII Gene F8C
Among Patients with Severe Hemophilia A
2002 - Mutation in brief #533, onlineSymptomatic Onset of Severe Hemophilia A in Childhood is Dependent on the Presence of Prothrombotic Risk Factors
2001 - Thromb Haemost 2001;85:218-20